MKRMF yields 1.37% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, MKRMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MKRMF + JNJ for your $10,000?
Valora Holding AG operates as a retailer in the convenience and food service sector in Europe. It operates through Retail and Food Service segments. The Retail segment operates small retail outlets in Switzerland, Germany, Luxembourg, and Austria. This segment also operates marketing and distribution systems for press, tobacco, and consumer products under the k kiosk, avec, Press & Books, ServiceStore DB, cigo formats, and U-store brands. The Food Service segment produces and sells lye bread, such as pretzels, baguettes, croissants, hot dogs, and sandwich snacks; and other bakery products under the BackWerk, Ditsch, Brezelkönig, and SuperGuud brand names. This segment also operates Caffè Spettacolo, a coffee-bar chain. The company was formerly known as Merkur Holding AG and changed its name to Valora Holding AG in July 1996. Valora Holding AG was founded in 1905 and is headquartered in Muttenz, Switzerland. As of September 30, 2022, Valora Holding AG operates as a subsidiary of Impulsora de Marcas e Intangibles S.A. de C.V. As of October 7, 2022, Valora Holding AG operates as a subsidiary of Impulsora de Marcas e Intangibles S.A. de C.V.
Full MKRMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.